Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Flexion Therapeutics revenue
Flexion Therapeutics's revenue is $85.6 million.
What is Flexion Therapeutics's revenue?
- Flexion Therapeutics's revenue growth from 2017 to 2020 is 23,999.15%.
- Flexion Therapeutics has 272 employees, and the revenue per employee ratio is $314,529.
- Flexion Therapeutics's peak quarterly revenue was $28.2M in 2021(q2).
- Flexion Therapeutics peak revenue was $85.6M in 2020.
- Flexion Therapeutics annual revenue for 2019 was 73.0M, 223.91% growth from 2018.
- Flexion Therapeutics annual revenue for 2020 was 85.6M, 17.26% growth from 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Flexion Therapeutics historical revenue
Flexion Therapeutics's peak revenue was $85.6M in 2020. The peak quarterly revenue was $28.2M in 2021(q2).
Flexion Therapeutics's revenue increased from $355.0k in 2017 to $85.6M currently. That's a 23,999.15% change in annual revenue.
Flexion Therapeutics annual revenue
Flexion Therapeutics annual revenue over time
| Fiscal year / year | Flexion Therapeutics revenue |
|---|---|
| 2017 | $355,000 |
| 2018 | $22.5M |
| 2019 | $73.0M |
| 2020 | $85.6M |
How accurately did Flexion Therapeutics' revenue projections match actual performance?
Flexion Therapeutics annual growth
Flexion Therapeutics saw the greatest revenue growth in 2018, when revenue increased by 6,244.79%.
Flexion Therapeutics had the lowest revenue growth in 2020, when revenue changed by 17.26%.
Flexion Therapeutics annual growth rate over time
| Year | Flexion Therapeutics growth |
|---|---|
| 2018 | 6245%↑ |
| 2019 | 224%↑ |
| 2020 | 17%↑ |
Flexion Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Flexion Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2017 | - | - | - | $355,000 |
| 2018 | $2.2M | $3.8M | $7.0M | $9.5M |
| 2019 | $10.6M | $17.0M | $21.8M | $23.7M |
| 2020 | $20.1M | $15.5M | $23.7M | $26.3M |
| 2021 | $24.6M | $28.2M | $21.3M | - |
Flexion Therapeutics jobs nearby
Do you work at Flexion Therapeutics?
Did Flexion Therapeutics meet its revenue projections?
Flexion Therapeutics financial information
| CEO | Michael D. Clayman M.d |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 272 |
| Date Founded | 2007 |
| Headquarters | Burlington, Massachusetts |
| Number of Locations | 1 |
| Revenue | $85.6M |
| Net Income | -$113,706,000 |
| Gross Proft | $66.3M (2020) |
| PE Ratio | -4.02 |
| Tax Rate | -0.0% |
| Market Capitalization | $456.6M |
| Total Assets | $251,926,000 |
| Ticker | FLXN |
Flexion Therapeutics jobs you might like
Flexion Therapeutics financing
Flexion Therapeutics received early financing of $33.0M on 2009-10-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $33M | 10/2009 |
| Series A | $9M | 01/2010 |
| Series B | $20M | 12/2012 |
| Post Ipo Debt | $30M | 08/2015 |
Flexion Therapeutics investors
| Investors | Security type |
|---|---|
| Versant Ventures | Series A |
| 5 Am Ventures | Series A |
| SOFINNOVA PARTNERS | Series A |
| Pfizer Venture Investments | Series A |
| Novo Ventures | Series B |
| Versant Ventures | Series B |
| 5 Am Ventures | Series B |
| Pfizer Venture Investments | Series B |
| SOFINNOVA PARTNERS | Series B |
| MidCap Financial | Post Ipo Debt |
| Silicon Valley Bank | Post Ipo Debt |
Flexion Therapeutics competitors
Flexion Therapeutics's top competitor, Vertex Pharmaceuticals, earned an annual revenue of $11.0B.
Flexion Therapeutics's smallest competitor is Trevena with revenue of $3.8M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 270 |
| Upsher-Smith Laboratories | $63,937 | $420.0M | 550 | 27 |
| Dermira | $88,797 | $79.2M | 333 | - |
| Exelixis | $108,978 | $2.2B | 484 | 175 |
| Spectrum Pharmaceuticals | $84,494 | $10.1M | 235 | - |
| Ariad Pharmaceuticals | $94,078 | $118.8M | 380 | - |
| Esperion Therapeutics | $75,747 | $332.3M | 218 | 47 |
| Achillion Pharmaceuticals | $75,385 | $15.0M | 56 | - |
| Forest Laboratories | $91,901 | $3.6B | 6,200 | - |
| ImmunoGen | $64,247 | $108.8M | 75 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Flexion Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Flexion Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Flexion Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Flexion Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Flexion Therapeutics. The data presented on this page does not represent the view of Flexion Therapeutics and its employees or that of Zippia.
Flexion Therapeutics may also be known as or be related to Flexion Therapeutics, Flexion Therapeutics Inc, Flexion Therapeutics Inc. and Flexion Therapeutics, Inc.